Carbidopa is a medicine used to help manage Parkinson's disease. It works by stopping the body from turning levodopa into dopamine. This helps reduce some of the side effects of levodopa, like nausea. It doesn't treat the symptoms of Parkinson's disease on its own.
Every report comes from a Lived member, sent anonymously.
Have you tried Carbidopa for Parkinson's Disease?
Carbidopa is a prescription medicine for Parkinson's disease that is always taken together with levodopa, the main medicine used to ease Parkinson's symptoms such as tremor, stiffness and slow movement. Carbidopa has no effect on those symptoms by itself. Its job is to help levodopa work at lower doses and with less nausea and vomiting. Most people get carbidopa already combined with levodopa in one tablet, such as Sinemet or generic carbidopa-levodopa. Carbidopa on its own, sold as Lodosyn and as generic 25 mg tablets, is added when a person's combination doses supply too little carbidopa to control nausea (usually less than about 70 mg of carbidopa a day), or occasionally when the two medicines need to be adjusted separately. It is approved for Parkinson's disease and for similar movement problems (parkinsonism) that can follow brain inflammation from an infection or poisoning with carbon monoxide or manganese.
Parkinson's symptoms develop as the brain loses cells that make dopamine, a chemical messenger that helps control movement. Dopamine taken as a medicine cannot pass from the bloodstream into the brain, but levodopa can, and the brain then converts it into dopamine. The difficulty is that an enzyme called dopa decarboxylase also converts much of a levodopa dose into dopamine in the rest of the body, before it reaches the brain. That stray dopamine causes nausea and vomiting, and it means large doses of levodopa are needed. Carbidopa blocks this enzyme outside the brain but does not readily enter the brain itself. More levodopa therefore reaches its target, and the amount of levodopa needed for the same effect falls by about three-quarters. Carbidopa does not make levodopa more effective at its best, and it does not prevent the side effects that come from levodopa's action in the brain.
Carbidopa comes as a 25 mg scored tablet taken by mouth at the same time as levodopa or carbidopa-levodopa, so it follows the same schedule, often several times a day. For someone already taking a combination tablet, a common approach is to add carbidopa with the first dose of the day and sometimes with later doses. The prescriber counts the carbidopa already in combination tablets, because total carbidopa from all products generally should not exceed 200 mg a day. Adding carbidopa for someone who has been taking levodopa alone works differently: levodopa is paused for at least 12 hours and then restarted at a much lower dose, since far less is needed once carbidopa is on board. This switch should follow the prescriber's specific instructions. Take doses at regular times, and do not add another carbidopa-levodopa product or change the schedule without the prescriber. Do not stop these medicines suddenly or cut the dose sharply. A rapid drop in levodopa treatment can, rarely, trigger a life-threatening reaction with high fever, very stiff or rigid muscles and confusion, and these signs need emergency medical care. If treatment has to pause, for example around surgery, the care team should plan for it.
Carbidopa itself causes few noticeable effects at usual doses; the side effects people notice come from the levodopa it accompanies, which now reaches the brain sooner and at lower doses. The most common problems are nausea and dyskinesias, which are involuntary twisting, jerking or writhing movements. Dyskinesias often mean the overall levodopa effect is too strong, and the prescriber may lower a dose. Dizziness or lightheadedness on standing, vivid dreams, trouble sleeping and confusion can also occur. Saliva, urine or sweat may turn dark red, brown or black; this is harmless but can stain clothing. Some people become very drowsy or fall asleep suddenly during daily activities, sometimes with no warning, and this has caused car crashes. Anyone who has dozed off unexpectedly or has marked daytime sleepiness should not drive and should tell the prescriber. Contact the prescriber right away about hallucinations (seeing or hearing things that are not there), paranoid or confused thinking, or new intense urges to gamble, spend, binge eat or pursue sex. People often do not recognize these urges in themselves, so observations from family members matter. Worsening depression or thoughts of suicide also need prompt attention.
Carbidopa with levodopa must not be combined with nonselective MAO (monoamine oxidase) inhibitors, an older group of antidepressants; they must be stopped at least two weeks before levodopa is started. The more selective type that blocks only the B form of the enzyme, used for Parkinson's disease (such as selegiline and rasagiline), can be taken with it, although the combination can cause marked drops in blood pressure on standing. Levodopa products are also not used in people with narrow-angle glaucoma, a less common form of the eye-pressure disease glaucoma. Several medicines can weaken levodopa's benefit, including many antipsychotic medicines such as risperidone, metoclopramide (a medicine for nausea and slow stomach emptying), the tuberculosis drug isoniazid and the seizure medicine phenytoin. Blood pressure medicines may need adjusting because the combination can cause lightheadedness on standing. Iron supplements, including multivitamins with iron, and high-protein meals can reduce or delay levodopa absorption, so a change in either is worth mentioning to the prescriber. People with Parkinson's disease have roughly two to six times the general population's risk of melanoma, a serious skin cancer. It is unclear whether Parkinson's medicines contribute, but regular skin checks, ideally by a dermatologist, are advised. Little is known about carbidopa's safety in pregnancy, so anyone pregnant or planning a pregnancy should discuss it with the prescriber.
When carbidopa is added to an existing levodopa regimen, nausea often eases, but not for everyone, and a trial of the medicine is the only way to find out. Because levodopa now acts more strongly and quickly, the first weeks often involve dose adjustments, and the prescriber will watch for involuntary movements, dizziness and changes in thinking. Repeated involuntary closing of the eyelids can be an early sign that the dose is too high. Carbidopa and levodopa ease symptoms but do not cure Parkinson's disease. Added carbidopa has not been shown to help people whose main problem is unpredictable swings between periods when levodopa is working and periods when it is not. Some people notice levodopa wearing off before the next dose is due, which is worth reporting. Long-term treatment involves regular follow-up visits, periodic blood tests of liver, kidney and blood-cell health, and routine skin checks.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Carbidopa, what you've noticed, or ask the community a question.